In the News

May 1, 2017

By Hannah Guzik

In an attempt to shield the state from federal policy changes, California legislators are working on a series of women’s health bills.

A bill introduced by Sen. Ed Hernandez of West Covina would require the state’s low-income health plan to continue ensuring access to reproductive health care even if the federal government changes its coverage.

April 24, 2017

Pharmaceutical companies need an intervention to address their addiction to prescription drug price gouging. Californians should demand that Big Pharma be more transparent about drug pricing habits and put an end to industry practices that state Sen. Ed Hernandez says benefit drugmakers at the expense of taxpayers.

April 18, 2017

By Ed Hernandez and Tom Steyer

Big Pharma is everywhere.

Ads for the latest and greatest “lifestyle” drugs clog our magazines and spill out of our TVs. Every ailment is now a disease with a name and a medication to match.

The truth is, we can’t avoid Big Pharma because it’s the only game in town. Thanks to government-authorized monopoly protections, we have no choice but to pay whatever price Big Pharma charges, no matter how high.

March 20, 2017


Una nueva propuesta de ley en California busca que las empresas farmacéuticas notifiquen a consumidores antes de elevar los precios de sus medicamentos.

La medida SB 17 también requeriría que los planes de salud reporten la proporción de lo que gastan en el costo de medicinas recetadas.

March 15, 2017

By Rebecca Plevin

A state senator has re-introduced a bill that would shine a light on some prescription drug price hikes.

March 15, 2017

By Melanie Mason

California Democrats, labor unions, health insurers and consumer advocacy groups — along with newly joined backer Tom Steyer, the billionaire activist — are restarting their effort to shed more light on prescription drug prices after a similar measure sputtered last year.

March 15, 2017

By Victoria Colliver

Billionaire activist Tom Steyer waded into the drug-pricing wars Wednesday, joining two California lawmakers in introducing the details of a new state bill designed to promote transparency in pharmaceutical costs.

March 15, 2017

By Ed Silverman

A California legislator is taking another stab at gaining transparency into drug pricing by introducing a bill that would require drug makers to notify state officials about planned price increases and to also justify price hikes. At the same time, the legislation would also require health plans to provide detailed information about drug costs and the portion of premiums attributed to this expense.